Cerecin Neurosciences

Latest News

1 / 6

Cerecin Expands Leadership Team with Appointment of Chief Medical Officer and Chief Operating Officer

01 September 2024
View More
Cerecin Bolsters Pipeline with a Strategic Acquisition From Boston Scientific

01 January 2024
View More
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders

1 December 2023
View More
Cerecin strengthens position in neurometabolism with addition to pipeline

19 September 2023
View More
Cerecin to Present New Infantile Spasms Data at the 35th Interna1onal Epilepsy Congress, Dublin 2023

30 August 2023
View More
Clinical Trial Data of Novel Metabolic Mechanism in Migraine: CER-0001, a Ketogenic Investigational Agent

30 June 2023
View More